Resistomap

What Resistomap does

Resistomap Oy is a Helsinki-based environmental diagnostics company founded in 2018 that quantifies antibiotic resistance genes (ARGs) and microbial resistance markers in water, wastewater, soil, sludge, sediment, aquaculture, livestock, and food samples using Takara Bio's SmartChip high-throughput qPCR platform combined with a curated portfolio of over 600 validated primer sets and a domain-specific 96-gene One Health panel. The company runs a central laboratory in Helsinki (Helsinki, Finland, at Elimäenkatu 15, 00510) equipped with QIAGEN QIAcube automation for DNA extraction and delivers results to customers through the Resistomap Platform, a cloud-based dashboard that converts quantitative gene data into standardised metrics including the Antibiotic Resistance Gene Index (ARGI), AMR Gene Removal, and AMR Comparative Risk Score, benchmarked against a proprietary database of 16,000+ environmental samples from 45 countries.

The core offering consists of two products: (i) project-based Laboratory & Data Analysis Services providing end-to-end customisable analysis from sampling design through results in roughly 10 working days, and (ii) the Water Biosecurity Platform, launched globally at the World AMR Congress in Philadelphia in September 2024 as a subscription-style biosecurity intelligence product specifically aimed at wastewater treatment plants, water utilities, and public health agencies seeking compliance with the EU Urban Wastewater Treatment Directive. Customer segments are organised vertically: primary use cases are water & wastewater utilities, public-health agencies, and academic research institutions, with secondary expansion into aquaculture, livestock, and food safety. The customer base spans 150+ organisations across 41 countries with 470+ projects supported cumulatively, and includes named logos such as CGIAR, NIVA, University of Helsinki, University of Warwick, University of Gothenburg, and Michigan State University.

Commercially, Resistomap operates a sales-led, enterprise field-sales motion with direct engagement via website demo requests, account managers (including a UK-based resource), and conference-driven pipeline (SETAC, World AMR Congress); pricing is quote-based and varies with gene-panel size (6 to 384 targets) and sample count, with dilution services starting at €100 per chip. The company is privately held and raised €2M in pre-seed funding in November 2023 (Ananda Impact Ventures lead, with Gaingels and a Business Finland R&D grant) to fund the transition from project-based lab services into a recurring biosecurity intelligence platform.

Name

Resistomap

Legal name

Resistomap Oy

Website

https://resistomap.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Resistomap is a Helsinki-based environmental diagnostics company that quantifies antibiotic resistance genes in water, wastewater, soil, and food samples using high-throughput qPCR, serving wastewater utilities, public health agencies, research institutions, and aquaculture/livestock operators through its lab services and Water Biosecurity Platform.

Ownership category

akta.pro rank

Product category

Environmental AMR Monitoring & Biosecurity Intelligence

NAICS

Testing Laboratories and Services (54138)

SIC

Services-Testing Laboratories (8734)

akta.pro primary industry

Microbiology & Pathogen Monitoring (Legionella, Coliform, HABs) (EUAHACAI)

akta.pro secondary industries

Antimicrobial Resistance (AMR) & Antibiotic Susceptibility Reference Networks (HLAJAIAF), Sampling Programs & Field Services (grab/composite sampling, chain-of-custody, logistics) (EUANAJAD), Water & Drain Monitoring for Environmental Pathogens (Drains, CIP Return, Process Water) (AFALAEAE), Microbiological Water Testing (Coliform/E. coli, HPC, Legionella) (AFALAJAD)

Keywords

• Antimicrobial resistance monitoring
• Environmental DNA analysis
• High-throughput qPCR
• Wastewater biosecurity surveillance
• AMR gene quantification

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Laboratory & Data Analysis Services: End-to-end AMR monitoring service from sampling to final SmartChip qPCR analysis and data delivery via the Resistomap Platform. Services include customisable gene panels (6 to 384 genes per chip), DNA extraction, and cloud-based results. Revenue is generated per project/sample batch, with pricing varying by gene selection and sample count.
2. Water Biosecurity Platform (SaaS): Cloud-based biosecurity intelligence platform providing ongoing AMR monitoring dashboards, visualisations, trend tracking, and standardised metrics (ARGI, removal efficiency scores, risk scores). Offered as a subscription service for WWTPs, water utilities, public health agencies, and environmental protection bodies.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Resistomap provides end-to-end environmental antimicrobial resistance (AMR) monitoring, combining laboratory SmartChip high-throughput qPCR analysis of environmental DNA samples with a cloud-based intelligence platform that quantifies, benchmarks, and visualises antibiotic resistance gene data. Its Water Biosecurity Platform delivers ongoing AMR surveillance dashboards and standardised metrics for water utilities, public health agencies, and researchers.

Product overview

Resistomap operates as a laboratory and data services company offering environmental AMR monitoring. The core offering consists of the Resistomap Platform (cloud-based intelligence dashboard) combined with Laboratory & Data Analysis Services (end-to-end from sampling to results). The Water Biosecurity Platform represents a specialized, sector-specific version targeting WWTPs and water utilities. All services utilize Takara Bio SmartChip qPCR technology for high-throughput gene detection, with results delivered via the Resistomap Platform dashboard and key metrics including ARGI, AMR Gene Removal, and Comparative Risk Score. The 96-gene package provides predefined gene targets optimized for One Health monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• Resistomap Platform: Cloud-based platform that processes quantitative AMR data and transforms it into clear, actionable insights, providing comprehensive information on AMR levels over time and across geographical locations.
• Water Biosecurity Platform

Products and services

• Water Biosecurity Platform A cloud-based biosecurity intelligence platform designed for wastewater treatment plants, water utilities, and public health organisations to monitor AMR levels in water systems. Features a 96-gene One Health package detecting AMR genes, pathogen markers, and human health risk indicators, converting quantitative measurements into trend visualisations and standardised metrics (ARGI, removal efficiency, risk scores).
• Resistomap Platform Cloud-based dashboard that processes quantitative AMR data from SmartChip qPCR measurements and transforms it into actionable insights, with interactive visualisations, heat maps of gene profiles, and key metrics including ARGI, AMR Gene Removal, and AMR Comparative Risk Score, plus secure role-based project sharing.
• Laboratory & Data Analysis Services End-to-end AMR monitoring service from experimental design and sampling support through automated DNA extraction (QIAcube) and high-throughput SmartChip qPCR analysis measuring up to 384 genes in parallel, with custom gene selection from 600+ validated primer sets and results delivered via the Resistomap Platform within 10 working days.

Quantifiable outcome

• Treatment plants showed ARGI values between 2.0 and 2.3 (European baseline ~2.0, global average ~2.4), demonstrating the ARGI metric's utility for benchmarking resistance levels across wastewater systems.
• +3 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core, supporting and minor.

• Takara BiocoreTechnology or Integration · 1 November 2024Technology partnership for SmartChip HT-qPCR systems. Resistomap uses Takara Bio's SmartChip Real-Time PCR system for high-throughput AMR gene quantification. Joint marketing during World AMR Awareness Week 2024. Takara Bio's printed chips containing the One Health gene panel are used in Resistomap's Water Biosecurity Platform. Resistomap presented alongside Takara Bio at World AMR Congress in Philadelphia.
• QIAGENsupportingTechnology or IntegrationVendor partnership for DNA extraction. Resistomap uses commercial QIAGEN DNA isolation kits, automated via QIAcube machine for standardised and reproducible DNA extraction from environmental samples.
• EMBARK Project (Coordinated by University of Gothenburg)minorStrategic or Co-development PartnerCollaborative project focused on establishing a monitoring baseline for antimicrobial resistance in key environments. Resistomap participated in EMBARK-related webinars and research coordination. The EMBARK project's goal of standardising AMR monitoring baselines aligns with Resistomap's service offering.

Scale indicators7 records

Recent moves4 records

Expansion highlights7 records

Broad incumbents

• LGC Group: LGC operates life sciences measurement and testing services including genomics, reference materials, and environmental analysis. It represents a scaled testing incumbent with overlapping capabilities in environmental AMR measurement.
• SGS: SGS provides global testing, inspection, and certification services including environmental water analysis. As a broad incumbent in environmental testing, SGS is a potential competitor or partner for scaled AMR monitoring contracts.
• Bureau Veritas: Bureau Veritas operates laboratory testing services across environmental, food, and water matrices globally. The company represents a scaled incumbent that could compete in regulated AMR testing markets.
• Bio-Rad Laboratories: Bio-Rad supplies qPCR instruments, reagents, and digital PCR systems (including the QX200 ddPCR) used in AMR research and diagnostics. As a major life science tools provider, it overlaps with Resistomap's technology stack and customer base.
• IDEXX Water Testing: IDEXX provides microbiology-based water testing products (e.g., Colilert, Enterolert) widely used by water utilities. Its installed base in WWTP laboratories makes it a natural adjacent competitor as AMR monitoring becomes regulated.
• Eurofins Water Testing: Eurofins operates a global network of environmental testing laboratories including water and wastewater analysis. While not specialized in AMR gene quantification, it is a major incumbent that could expand into Resistomap's niche.

Direct peers

• CosmosID: CosmosID provides next-generation sequencing-based microbial identification and AMR gene profiling services for environmental, food, and clinical samples. While using metagenomics rather than qPCR, it targets overlapping customers in AMR surveillance.
• DNASense: Denmark-based DNASense provides environmental DNA and microbiome analysis services for water, soil, and sediment samples, overlapping directly with Resistomap's environmental surveillance offerings. Both target AMR and microbial community profiling using molecular methods.
• Microbe Investigations Switzerland (MIS): MIS offers molecular microbiology services including pathogen detection and AMR gene analysis in environmental and water samples. The company competes directly with Resistomap in the European environmental AMR testing market.

Emerging players

• Noscendo: German diagnostics company applying NGS and bioinformatics for pathogen and AMR detection. While primarily clinical, Noscendo's technology stack (bioinformatics + molecular detection) overlaps with Resistomap's data science approach to AMR analytics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/resistomap
• Facebookfacebook.com/resistomap
• LinkedInlinkedin.com/company/resistomap
• Instagraminstagram.com/resistomap

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Resistomap